Key stats
About MIRAE ASSET GBL INVMTS (HK)LTD GLOBAL X CHINA BIOTECH ETF HKD
Home page
Inception date
Jul 25, 2019
Replication method
Physical
Dividend treatment
Distributes
Income tax type
Capital Gains
Primary advisor
Mirae Asset Global Investments (Hong Kong) Ltd.
ISIN
HK0000516697
The Global X China Biotech ETF seeks to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Underlying Index.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Cash
Stocks63.22%
Health Technology63.22%
Bonds, Cash & Other36.78%
Cash36.14%
Miscellaneous0.64%
Stock breakdown by region
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
2820 assets under management is 438.20 M HKD. It's risen 14.77% over the last month.
2820 fund flows account for −54.46 M HKD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 2820 doesn't pay dividends to its holders.
2820 shares are issued by Mirae Asset Global Investments Co., Ltd. under the brand Global X. The ETF was launched on Jul 25, 2019, and its management style is Passive.
2820 expense ratio is 0.68% meaning you'd have to pay 0.68% of your investment to help manage the fund.
2820 follows the Solactive China Biotech Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
2820 invests in stocks.
2820 price has risen by 15.95% over the last month, and its yearly performance shows a 38.21% increase. See more dynamics on 2820 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 13.57% over the last month, showed a 13.28% increase in three-month performance and has increased by 35.90% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 13.57% over the last month, showed a 13.28% increase in three-month performance and has increased by 35.90% in a year.
2820 trades at a premium (0.56%) meaning the ETF is trading at a higher price than the calculated NAV.